What to expect from GLP-1 side effects and how to manage them well. These articles cover common issues like nausea and digestion, rarer risks worth knowing, and practical steps to stay safe throughout treatment.
Side Effects & Safety
GLP-1 medications like semaglutide were developed for diabetes and weight loss, but researchers are now investigating whether they can also quiet cravings for alcohol, opioids, and other substances. A program in Rhode Island is among the first to explore this in a clinical setting. Here is what patients and families need to know right now.
Some people taking GLP-1 medications like Ozempic and Wegovy report an unpleasant side effect called "Ozempic breath." This article explains the likely causes behind this phenomenon, how long it typically lasts, and practical steps you can take to minimize it while staying on track with your weight loss goals.
A widow has gone public with a warning following her husband's death, which she links to his use of Ozempic. While investigations are ongoing, her story is a sobering reminder that no medication is without risk — and that informed, supervised use is non-negotiable.
A landmark clinical trial published in the New England Journal of Medicine found that semaglutide significantly reduced major cardiovascular events in people with obesity who don't have diabetes. For anyone on or considering GLP-1 therapy, this changes the conversation. Here's what the science actually says — and what it means for your health beyond the scale.
What 3,000+ Ozempic and Wegovy lawsuits reveal about risks.
Common Wegovy side effects and how to manage each one.
Why Ozempic increases caffeine sensitivity and how to adjust.
Ozempic alcohol intolerance: Why drinks feel stronger